{
    "nctId": "NCT00883181",
    "briefTitle": "A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy",
    "officialTitle": "A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Small Cell Lung Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1370,
    "primaryOutcomeMeasure": "Percentage of Participants With Febrile Neutropenia (FN)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects greater than or equal to 18 years old with breast, ovarian or lung cancer receiving chemotherapy in any schedule, e.g. dose dense or standard chemotherapy.\n* These subjects must have an Investigator assessed risk of febrile neutropenia (FN) \u226520% (based on 2006 European Organisation for Research and Treatment of Cancer (EORTC) G-CSF Guidelines\n\nExclusion Criteria:\n\n- Subjects with concurrent administration of radiotherapy are not eligible (previous radiotherapy is permitted if terminated at least 2 weeks prior to commencing applicable chemotherapy in this study).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}